Estación Experimental del Zaidín -ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2012

  1. 5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer

    International Journal of Nanomedicine, Vol. 7, pp. 95-107

2011

  1. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 65, Núm. 4, pp. 260-270

2010

  1. E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents

    International Journal of Oncology, Vol. 37, Núm. 6, pp. 1503-1514

  2. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 1, pp. 69-78

  3. Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway

    Experimental Dermatology, Vol. 19, Núm. 4, pp. 363-371

2009

  1. The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo

    Journal of Molecular Medicine, Vol. 87, Núm. 9, pp. 899-911

2008

  1. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells

    International Journal of Oncology, Vol. 33, Núm. 1, pp. 121-127

2003

  1. Inhibition of growth and induction of apoptosis in human breast cancer by transfection of gef gene

    British Journal of Cancer, Vol. 89, Núm. 1, pp. 192-198

  2. Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle

    Cancer Science, Vol. 94, Núm. 6, pp. 564-568